Source disclosure: March 05, 2026, 16:00 JST
Published by Pulse News Wire: March 05, 2026, 16:17 JST
Monstarlab Inc. [5255.T]
TOKYO, Mar 05 (Pulse News Wire) – Monstarlab Inc. (5255.T) announced today that its board of directors, held on March 05, 2026, resolved to reduce the capital stock and surplus fund amounts and dispose of surplus funds at the upcoming 20th regular shareholders' meeting scheduled for March 31, 2026.
The reduction aims to address accumulated losses in retained earnings and improve the company's financial health while ensuring flexibility and agility in future capital policies. According to the Companies Act, the capital stock amount will decrease from ¥1,171,271,012 to ¥100,000,000, and the surplus fund amount will drop from ¥1,096,271,012 to ¥25,000,000. Both reductions will be transferred to other capital reserves, which will then partially replenish the accumulated loss reserve.
Additionally, the company plans to transfer ¥573,031,670 from other capital reserves to retained earnings to cover deficits. The adjustments will take effect after shareholder approval at the annual general meeting on March 31, 2026, followed by creditor objections until May 8, 2026, and the final implementation on May 13, 2026. This move will not affect the total number of outstanding shares or per-share net assets.
The company expects minimal impact on its performance, contingent upon shareholder approval during the upcoming meeting.
AI-translated content. 🟢 Confidence: High See terms • Original filing